Viking Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.
CEOBrian Lian
CEOBrian Lian
Employees36
Employees36
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2012
Founded2012
Employees36
Employees36
VKTX Key Statistics
Market cap3.83B
Market cap3.83B
Price-Earnings ratio-15.99
Price-Earnings ratio-15.99
Dividend yield—
Dividend yield—
Average volume2.77M
Average volume2.77M
High today$35.42
High today$35.42
Low today$33.85
Low today$33.85
Open price$34.65
Open price$34.65
Volume2.21M
Volume2.21M
52 Week high$52.58
52 Week high$52.58
52 Week low$18.92
52 Week low$18.92
Stock Snapshot
As of today, Viking Therapeutics(VKTX) shares are valued at $33.90. The company's market cap stands at 3.83B, with a P/E ratio of -15.99.
During the trading session on 2025-12-02, Viking Therapeutics(VKTX) shares reached a daily high of $35.42 and a low of $33.85. At a current price of $33.90, the stock is +0.1% higher than the low and still -4.3% under the high.
Trading activity shows a volume of 2.21M, compared to an average daily volume of 2.77M.
The stock's 52-week range extends from a low of $18.92 to a high of $52.58.
The stock's 52-week range extends from a low of $18.92 to a high of $52.58.
Analyst ratings
94%
of 18 ratingsBuy
94.4%
Hold
5.6%
Sell
0%
People also own
Based on the portfolios of people who own VKTX. This list is generated using Robinhood data, and it’s not a recommendation.